JP Morgan Raises PT On CR Bard To $104

May 31, 2011 6:04 AM | 8 seconds read |

JP Morgan has raised the price target on CR Bard BCR from $97 to $104 and maintains its Neutral rating.

Posted In: Price Target Analyst Ratings CR Bard Health Care Health Care Equipment JP Morgan

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.